Annual Report 2012 - Acino

20
ACINO | OUR BUSINESSES
Financial performance
(in EUR million)
Sales Cont. margin
1.0 100.4 0.7 17.7
2011 2012 2011 2012
BtC share of Group results
39% of
sales
Top 5 countries/regions
• Iraq
• Saudi Arabia
• French-speaking Africa
• United Arab Emirates
• Ecuador
Top 5 products
• Olfen (pain management)
• Gasec (gastro-intestinal)
• Spasfon (gastro-intestinal)
• Neurorubine (pain)
• Mesporin (antiinfective)
37% of
contribution margin
BtC: Taking “Acino Switzerland” global
what we do
Acino markets medicines under its own brand “Acino Switzerland” in up and coming economies
around the globe, supporting healthcare professionals in their mission to treat
patients in the best possible way.
Market opportunity
Pharma growth in emerging markets will continue to be robust as governments are striving
to expand access to healthcare on the back of favorable economic developments. In addition,
growing awareness of quality in the middle and upper classes of society increases the
demand for more value-added products, preferably of Swiss/EU origin. As a Swiss company
and with a product portfolio of excellent pharmaceuticals, Acino is optimally positioned to
seize this business opportunity.
Broad product portfolio
At present, Acino markets a portfolio of 42 pharmaceuticals (including brands acquired
from Mepha/Cephalon) in the therapeutic areas of pain, urology, oncology, antimycotics,
cardiovascular, neurology (CNS), infectious disease, rheumatology, gastroenterology, as
well as in the field of malaria in over 80 countries. Complementing the well-established
drug portfolio, products from own development and selected in-licensings are gradually
being registered and rolled out.
“Acino Switzerland” – worldwide
Four regional representative offices – in Manila for Asia, in Nairobi for Subsahara Africa, in
Malta/Paris for the Middle East and North Africa (MENA), and Acino Latino-Americana S.A.
in Panama for LATAM – oversee the country-specific marketing and registration activities
managed by local partners. On our behalf, these partners handle product registrations and
deploy a dedicated sales force to promote Acino’s product range. In all regions, we have
built relationships with important players and established a reputation as a reliable provider
of Swiss quality pharmaceuticals.
Quality wins
Committed to highest Swiss quality standards, our effective and safe medications are a
valuable addition to the therapeutic armamentarium of healthcare professionals worldwide.
Welcome to Acino Switzerland – Ensuring Effective Relief.